DISEASE INDICATIONS: Atopic Dermatitis
MANUFACTURER: Pfizer Limited
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Medicines & Healthcare products Regulatory Agency (MHRA)
Cibinqo (abrocitinib) is an FDA-approved prescription medication used to treat mild to severe eczema in patients aged 12 years and above. The medication works by blocking the action of certain cytokines, which are proteins involved in inflammation processes.